Commerzbank Aktiengesellschaft FI decreased its holdings in shares of Canopy Growth Corp (NYSE:CGC) by 0.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 154,464 shares of the marijuana producer’s stock after selling 842 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Canopy Growth were worth $3,542,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the business. Kistler Tiffany Companies LLC raised its position in shares of Canopy Growth by 43.0% during the 2nd quarter. Kistler Tiffany Companies LLC now owns 1,097 shares of the marijuana producer’s stock valued at $44,000 after acquiring an additional 330 shares during the last quarter. AllSquare Wealth Management LLC raised its position in shares of Canopy Growth by 8.3% during the 2nd quarter. AllSquare Wealth Management LLC now owns 4,500 shares of the marijuana producer’s stock valued at $182,000 after acquiring an additional 344 shares during the last quarter. Tradewinds Capital Management LLC raised its position in shares of Canopy Growth by 41.9% during the 2nd quarter. Tradewinds Capital Management LLC now owns 1,202 shares of the marijuana producer’s stock valued at $48,000 after acquiring an additional 355 shares during the last quarter. Pictet Asset Management Ltd. raised its position in shares of Canopy Growth by 0.5% during the 2nd quarter. Pictet Asset Management Ltd. now owns 77,571 shares of the marijuana producer’s stock valued at $3,138,000 after acquiring an additional 400 shares during the last quarter. Finally, Oppenheimer & Co. Inc. raised its position in shares of Canopy Growth by 0.7% during the 2nd quarter. Oppenheimer & Co. Inc. now owns 58,845 shares of the marijuana producer’s stock valued at $2,371,000 after acquiring an additional 411 shares during the last quarter. Institutional investors own 9.27% of the company’s stock.

CGC opened at $20.21 on Friday. The company has a quick ratio of 9.03, a current ratio of 10.37 and a debt-to-equity ratio of 0.13. Canopy Growth Corp has a 12 month low of $17.89 and a 12 month high of $52.74. The company has a fifty day simple moving average of $24.04 and a 200 day simple moving average of $35.75. The stock has a market cap of $7.22 billion, a P/E ratio of -12.71 and a beta of 3.77.

Canopy Growth (NYSE:CGC) last released its quarterly earnings data on Wednesday, August 14th. The marijuana producer reported ($0.23) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.29) by $0.06. Canopy Growth had a negative net margin of 647.47% and a negative return on equity of 13.01%. The business had revenue of $67.65 million during the quarter, compared to analysts’ expectations of $85.97 million. On average, equities research analysts expect that Canopy Growth Corp will post -1 earnings per share for the current fiscal year.

CGC has been the subject of several recent research reports. Seaport Global Securities cut shares of Canopy Growth from a “buy” rating to a “neutral” rating in a research report on Monday, October 14th. Oppenheimer initiated coverage on shares of Canopy Growth in a research report on Tuesday, September 17th. They set a “market perform” rating for the company. Benchmark dropped their target price on shares of Canopy Growth from $100.00 to $60.00 and set a “buy” rating for the company in a research report on Friday, August 16th. Bank of America cut shares of Canopy Growth from a “buy” rating to a “neutral” rating and set a $27.00 target price for the company. in a research report on Friday, September 27th. Finally, Piper Jaffray Companies dropped their target price on shares of Canopy Growth from $49.00 to $40.00 and set an “overweight” rating for the company in a research report on Tuesday, October 1st. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the company’s stock. Canopy Growth has a consensus rating of “Hold” and an average price target of $47.39.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Featured Article: Quantitative Easing

Want to see what other hedge funds are holding CGC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Canopy Growth Corp (NYSE:CGC).

Institutional Ownership by Quarter for Canopy Growth (NYSE:CGC)

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.